Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Apr 10, 2023 (4 years ago)

Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Subpotent Drug: Out of specification results for low potency was obtained.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44

Affected NDC 70004-0085-44

Compare with the code on your package — it is the most precise check available.

Drug: Oxytocin

Recalling firm
SCA Pharmaceuticals
NDC code
70004-085-44
Origin
CT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0555-2023 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Oxytocin recalls

See all
Class III · Low risk

Oxytocin synthetic

Labeling: Not Elsewhere Classified

Terminated Labeling / mix-up Denver Solutions, LLC DBA Leiters Health NDC 71449-157-70 D-0070-2024
Class II · Moderate risk

oxyTOCIN

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1134-2023

Other recalls by SCA Pharmaceuticals

All 2023 recalls